MACM
PHAR

MAC Alpha Capital Management’s Pharming Group PHAR Stock Holding History

MAC Alpha Capital Management’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.95M Buy
+2,148,144
New +$31.1M 1.37% 21

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
SGFG
Silver Grove Financial Group Orchard Park, New York $185M AUM 28.01% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

MAC Alpha Capital Management's PHAR Position: Q2 2026 in Review

MAC Alpha Capital Management opened a new position in Pharming Group (PHAR) in Q2 2026: 2,148,144 shares worth $2.95M. The stake represents 1.37% of the portfolio and ranks #21 among its holdings.

18 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • MAC Alpha Capital Management held 2,148,144 shares of Pharming Group worth $2.95M as of Q2 2026.
  • Pharming Group was a new MAC Alpha Capital Management position in Q2 2026.
  • Pharming Group made up 1.37% of MAC Alpha Capital Management's portfolio in Q2 2026, its #21 holding.
  • 18 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on MAC Alpha Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.